CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Palliative and Supportive Care

Consultant.
 

Multiple Sclerosis and Epstein-Barr Virus: Is there a Connection?

By Sreeram Ramagopalan, PhD | September 24, 2012
Dr Ramagopalan is Programme Leader at the University of Oxford, United Kingdom. He is the author or coauthor of over 100 peer-reviewed articles on multiple sclerosis.

Although genetics risk explains the familial clustering of multiple sclerosis (MS), it cannot fully explain the geographic distribution of MS and the changes in risk that occur with migration. Infections have been suggested as a possible explanation. While many agents have been tested, the most convincing candidate for involvement in MS is Epstein-Barr virus (EBV).

EBV is present in all populations and infects over 90% of individuals within the first decades of life. EBV infection results in a life-long persistence of the virus in the host’s B-lymphocytes. EBV infection has been associated with numerous cancers, including Burkitt lymphoma, Hodgkin lymphoma, and nasopharyngeal carcinoma.

(MORE: Sex Ratio of Multiple Sclerosis)

Primary EBV infection is usually at an early age and is typically asymptomatic. However, primary infection during adolescence or adulthood often manifests as infectious mononucleosis, which has been associated with a more than 2-fold increased risk of MS.1

Mononucleosis, like MS, is rare in conditions of poor hygiene (ie, in developing countries), where virtually all children are infected with EBV in the first years of life.

Perhaps most importantly, MS risk is extremely low in individuals who are EBV-negative. However, risk increases sharply following EBV infection, as shown in a recent longitudinal study.2

The biological mechanism by which EBV may cause MS is not yet known. It remains to be determined whether EBV influences the disease course of MS.

References
1. Handel AE, Williamson AJ, Disanto G, et al. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One. 2010;5(9). pii: e12496.

2. Levin LI, Munger KL, O’Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. 2010;67:824-830.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

MS primary care

Multiple Sclerosis: Role of Physical Therapy in Disease-Related Mobility Deficits

Simplified Testing for Cognitive Function in Multiple Sclerosis

Guidance for Treating Pediatric Multiple Sclerosis With Grown-Up Medications

Multiple Sclerosis: What Triggers Exacerbations?

Multiple Sclerosis: 10 Things Primary Care Providers Need to Know Now

The Importance of Bone Health in Multiple Sclerosis

Disease Modifying Therapies: Do They Modify Short- and Long-Term in Multiple Sclerosis?

Pregnancy, Breast Feeding—and Risk of Relapse in Multiple Sclerosis

Multiple Sclerosis and Epstein-Barr Virus: Is there a Connection?

The Genetics of Multiple Sclerosis: 4 Key Points

Venous Thromboembolism and Multiple Sclerosis

In Multiple Sclerosis, Motivational Interviewing Can Improve Exercise Experience

Smoking and Multiple Sclerosis

Complementary Therapies in Multiple Sclerosis: Why Mind-Set Is Everything

Wellness Program Improves Self-Efficacy in Multiple Sclerosis

Multiple Sclerosis and the Primary Care Physician’s Key Role

Intrathecal Methotrexate: A Treatment Option for Patients with Progressive Multiple Sclerosis?

Angioplasty Affords Symptom Relief for Patients With Multiple Sclerosis

Sex Ratio of Multiple Sclerosis






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Palliative And Supportive Care
Evidence on Palliative And Supportive Care
Guidelines on Palliative And Supportive Care
Patient Education on Palliative And Supportive Care
Clinical Trials on Palliative And Supportive Care
Practical Articles on Palliative And Supportive Care
Research and Reviews on Palliative And Supportive Care
All "Palliative And Supportive Care" results



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy